Canopy Growth (TSE:WEED) Issues Earnings Results

Canopy Growth (TSE:WEED) posted its earnings results on Friday. The company reported C($0.10) EPS for the quarter, FiscalAI reports. The company had revenue of C$81.37 million during the quarter. Canopy Growth had a negative return on equity of 29.85% and a negative net margin of 73.95%.

Canopy Growth Stock Performance

Shares of WEED stock traded down C$0.03 on Friday, reaching C$0.92. The stock had a trading volume of 2,157,543 shares, compared to its average volume of 1,468,449. The company has a debt-to-equity ratio of 40.27, a quick ratio of 2.32 and a current ratio of 3.04. Canopy Growth has a 1 year low of C$0.84 and a 1 year high of C$3.28. The stock has a market cap of C$389.19 million, a P/E ratio of -1.37, a price-to-earnings-growth ratio of -0.01 and a beta of 2.07. The company has a 50 day simple moving average of C$1.18 and a 200 day simple moving average of C$1.38.

Insider Buying and Selling

In other Canopy Growth news, Director David Angelo Lazzarato sold 22,380 shares of the stock in a transaction dated Monday, September 28th. The stock was sold at an average price of C$1.29, for a total value of C$28,870.20. Following the transaction, the director owned 108,237 shares of the company’s stock, valued at approximately C$139,625.73. This represents a 17.13% decrease in their ownership of the stock. Insiders sold a total of 43,492 shares of company stock worth $56,105 in the last three months. 0.21% of the stock is currently owned by corporate insiders.

Canopy Growth Company Profile

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands.